The latest announcement is out from XORTX Therapeutics Inc ( (TSE:XRTX) ).

Gout Gout remains unfazed by constant comparisons to Usain Bolt, even from the man himself. Despite being widely tipped as the next global sprinting superstar, the 17-year-old is handling the pressure ...

XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therapeutics highlighted newly published, large-scale genetic research ...

Teenage sprinting sensation Gout Gout is taking the track world by storm. Before graduating high school, the 18-year-old was ...

Athletics’ breakout star of 2025 is taking a gap year before university and says the break will help him focus more on the track ...

Australians shone on the global stage in 2025, while there was more myth-making and dynasties born closer to home ...

Australian sprint sensation Gout Gout, who has been compared to Usain Bolt, bought a house for his family after the teenager ...

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...

For anyone unfamiliar with gout - and I envy you - it’s a condition that announces itself with all the subtlety of a fire ...

High uric acid, or hyperuricemia, quietly affects countless people-and often sparks painful gout attacks or kidney troubles ...

Although rates vary widely between countries, the total number of young people with the condition is expected to continue rising through 2035.

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout ...